Contemporary hormone replacement therapy (HRT) was not associated with an increased risk of heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of more than 52,000 women in Israel. The findings from this independent, preliminary research will be presented at the American Heart Association's Scientific Sessions 2026. The meeting is Nov. 6–9 in Chicago.
Long-term study finds modern hormone replacement therapy not linked to heart disease risk
A long-term study involving over 52,000 women in Israel found that contemporary hormone replacement therapy is not linked to increased heart disease risk. The findings will be presented at the American Heart Association's Scientific Sessions 2026. This research may influence healthcare practices in Iran regarding women's health.
👥 Key Players
📰 What Happened
A large study involving over 52,000 women in Israel found that contemporary hormone replacement therapy does not increase the risk of heart disease. These findings will be shared at an upcoming American Heart Association conference.
- The study analyzed health data from women aged 45 to 59.
- No link was found between hormone replacement therapy and heart-related risks.
💡 Why It Matters
📚 Background
Hormone replacement therapy is often used to alleviate menopausal symptoms, but its safety regarding heart disease has been debated. This study provides new insights into its risks.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%